Ars Technica
US · 1 hrs ago
✦ 78✓ Factual
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
Moderna has received $50 million in funding to accelerate development of an mRNA vaccine targeting Bundibugyo ebolavirus, amid an active Ebola outbreak.
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!